Conference Programme


Hungry for Knowledge About Appetite Stimulants

Apr 20, 2020
Clinical Theater 2
Internal Medicine

Hyporexia or dysrexia is a common problem in companion animal practice. In recent years, our understanding of what drives or inhibits food intake has improved substantially, and the FDA has recently approved two drugs for this purpose in companion animals.
In this lecture, we will discuss the causes and consequence of hyporexia or anorexia in both dogs and cats. We will then review a logical approach to the patient with inadequate intake, and talk about how best to use an appetite stimulant. The mechanism of action of the two approved drugs will be outlined, along with suggestions for most effective use.

  • At the end of this lecture, attendees will be able to:
  • - Explain the processes that drive or inhibit food intake
  • - Discuss the mechanism of action of mirtazapine
  • - Discuss the mechanism of action of the ghrelin receptor agonists
Audrey Cook, BVM&S, MRCVS, MSc Vet Ed, DACVIM (SAIM), DECVIM-CA, DABVP (Feline), Professor, Small Animal Internal Medicine - Texas A&M University College of Vet Medicine and Biomedical Sciences